	FM-VP4
Safety
Hypercholesterolemia
Pharmacokinetics
Plant sterols
	weeks
dose
single dose
dose group
cholesterol
phase 2
treatment
adverse events
FM-VP
physical examination
DACP
LDL-C
multiple dose level
concentrations
phase
subjects
group
plant stanols
tablets
levels
significant
study
decrease
men
data not
plasma
lower
percentage change
low-density lipoprotein cholesterol
noncompliant
higher doses
baseline
pharmacokinetics
placebo group
DASP
plant sterol-
placebo
AUC
lipoproteins
study protocol
stanols
urinalysis
blood sample
normal
single
sitostanol
increase
time
events
active
stanol-containing products

